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Abstract
Purpose: This study investigates whether a machine-learning-based system can predict the rate of cognitive decline in mildly
cognitively impaired patients by processing only the clinical and imaging data collected at the initial visit.
Approach: We built a predictive model based on a supervised hybrid neural network utilizing a 3-Dimensional Convolutional
Neural Network to perform volume analysis of Magnetic Resonance Imaging and integration of non-imaging clinical data at the
fully connected layer of the architecture. The experiments are conducted on the Alzheimers Disease Neuroimaging Initiative
dataset.
Results: Experimental results confirm that there is a correlation between cognitive decline and the data obtained at the first visit.
The system achieved an area under the receiver operator curve (AUC) of 0.70 for cognitive decline class prediction.
Conclusion: To our knowledge, this is the first study that predicts slowly deteriorating/stable or rapidly deteriorating classes by
processing routinely collected baseline clinical and demographic data (Baseline MRI, Baseline MMSE, Scalar Volumetric data,
Age, Gender, Education, Ethnicity, and Race). The training data is built based on MMSE-rate values. Unlike the studies in the
literature that focus on predicting Mild Cognitive Impairment-to-Alzheimer‘s disease conversion and disease classification, we
approach the problem as an early prediction of cognitive decline rate in MCI patients.
Keywords: Computer-aided detection/diagnosis, Alzheimers Disease in the early stages, Cognitive decline, Mild cognitive
impairment, Baseline Visit
1. Introduction
Mild Cognitive Impairment (MCI) is an intermediate stage
between Cognitively Normal (CN) and Alzheimers Disease
(AD) [1]. The patients in the MCI phase have a varied prog-
nosis such that the cognitive functions of some MCI patients
deteriorate, while others remain stable or improve [2][3]. Al-
though there has not been any successful treatment to reverse
cognitive decline, to date, therapy to decelerate its progression
is likely to be most beneficial if it is applied early [4][5]. In this
study, we investigate whether a machine learning-based system
can predict the rate of cognitive decline in patients with diag-
nosed MCI by processing only the clinical and imaging data
obtained at the initial visit.
Prior studies have reported on biomarkers and the predic-
tion of MCI-to-AD conversion [6][7][8][4][9]. Unlike earlier
1Data used in preparation of this article were obtained from the Alzheimers
Disease Neuroimaging Initiative (ADNI) database (adni.loni.usc.edu). As
such, the investigators within the ADNI contributed to the design and imple-
mentation of ADNI and/or provided data but did not participate in analysis
or writing of this report. A complete listing of ADNI investigators can be
found at: http://adni.loni.usc.edu/wp-content/uploads/how_to_
apply/ADNI_Acknowledgement_List.pdf
studies, we investigate the feasibility of predicting the rate of
cognitive decline in MCI patients at the first visit by process-
ing only the baseline MRI and routinely collected clinical data.
We built a deep-learning-based predictive model that integrates
imaging and non-imaging demographic and clinical data in the
same neural network architecture. The system consists of 3
main inputs: 1) MRI brain images, 2) scalar volumetric fea-
tures, and 3) demographic and clinical data. MRI brain scans
are provided to the network as sequential DICOM images and
processed through a 3-Dimensional Convolutional Neural Net-
work (3D-CNN). The scalar volumetric features extracted us-
ing FreeSurfer [10] represent selected brain substructures and
included total intracranial volume, whole-brain volume, and re-
gional volumes of the hippocampus, entorhinal cortex, fusiform
gyrus, and medial temporal lobe; this scalar data is integrated
into the system at the fully connected layer of the architecture.
The demographic and clinical information included in the neu-
ral network architecture are the ones that are routinely collected
at the initial clinical visit, and include age, gender, years of ed-
ucation, ethnicity, race, and baseline mini-mental score exam-
ination score. The proposed predictive model is illustrated in
Figure 2.
We supervised the predictive model with the change in Mini-
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Mental State Examination (MMSE) scores [11][12] with the
MCI subjects grouped clinically according to (i) slow cogni-
tive decline, and (ii) fast cognitive decline. The resulting model
processes the clinical data obtained at the baseline visit and pre-
dicts the patients cognitive condition as either slowly deteriorat-
ing/stable or rapidly deteriorating. The analysis is performed on
publicly available Alzheimers Disease Neuroimaging Initiative
(ADNI) dataset (c.f., Section 2.1).
2. Materials and Methods
2.1. Data
The data used in this study were obtained from the
ADNI [13], which is an ongoing multi-center study. The
primary goal of ADNI has been to test whether serial MRI,
positron emission tomography (PET), other biological markers,
and clinical and neuropsychological assessment can be com-
bined to measure the progression of MCI and early AD. The
subjects in the dataset were diagnosed as AD, MCI, Subjective
Memory Concern, or Cognitively Normal (CN) based on Mini-
Mental State Examination (MMSE) scores. The enrolled sub-
jects received multiple longitudinal follow-up visits over sev-
eral years, as specified by the ADNI protocol. For our research,
we utilize data on ADNI patients who were clinically diagnosed
as MCI at their baseline visits. A total of 569 subjects were in-
cluded. The demographics and clinical characteristics of the
subjects are summarized in Table 1.
Label MCI
Number of Patients 569
Age - mean [range] 76 [55 - 92]
Gender [Female - Male] F:241 M:328
Education - mean [range] 16 [6 - 20]
Ethnicity Not Hispanic / Hispanic
Race White - Black - Asian
Baseline MMSE score - mean [range] 28 [23 - 30]
Table 1: Characteristics of the study subjects. MMSE- Mini-Mental State Ex-
amination. MCI - Mild Cognitive Impairment.
The MMSE, which is a 30-point test, is a cognitive assess-
ment tool [11][12], and we used the rate of decline in MMSE
scores to supervise the system. Changes in MMSE scores in
follow-up visits demonstrate the patients condition in terms of
cognitive capabilities. A decrease in MMSE score reflects de-
terioration in cognitive capabilities; if a patients cognitive ca-
pability is stable, the MMSE scores remain relatively stable.
We model the change in MMSE scores by fitting a line to the
scores obtained at follow-up visits. The slope of the line indi-
cates the rate of cognitive loss. A patient who has faster cogni-
tive deterioration would have a higher absolute value of slope.
A slope close to zero indicates that the cognitive decline is sta-
ble. In this document, the Rate of Cognitive Decline term will
refer to the slope of the decline. The predictive model is binary.
Therefore, the rate of cognitive decline is converted to binary
variables using a threshold of -0.05 points/month, such that pro-
gressive rapidly deteriorating level of cognition is defined as a
rate of decrease exceeding 0.6 points/year. This threshold ap-
proximates the mean and the median rate change for this cohort.
The rate of cognitive decline distribution of the study subjects
is shown in Figure 1.
Figure 1: The rate of cognitive decline distribution of the study subjects
2.2. The System Pipeline
The predictive model learns the mapping function from input
data to the target output. Let V be the imaging sequence, D be
the corresponding clinical data, y be the target class, and f (.)
represent the mapping function between input data and output
labels. The model can be formulated as
yi = f (Vi,Di) (1)
for each subject i in N, where N is the number of patients with
MCI in the training data. Clinical data include age, gender,
baseline MMSE score, education, ethnicity, and race. We also
use brain volumes as supporting scalar features, which are com-
puted with an open-source library (FreeSurfer) that analyses
and visualizes structural and functional neuroimaging data [10].
Specifically used scalar features are whole-brain volume and re-
gional volumes of the hippocampus, entorhinal cortex, fusiform
gyrus, and medial temporal lobe. The brain volumes of each
subject are available in the ADNI [13]. We pose the problem as
a supervised classification task, with training subjects classified
into two groups based on the rate of MMSE (c.f., Figure 1). The
output variable y ∈ (0, 1) denotes the target classes, 0 represents
slowly deteriorating/stable class, and 1 represents rapidly dete-
riorating class. The proposed system is illustrated in Figure 2.
2.3. Pre-processing
We apply pre-processing techniques to each MRI volume V
and corresponding clinical data D before the training. The MRI
sequences are skull-stripped, which includes removal of non-
cerebral tissue (calvaria, scalp, and dura) [14]. The skull-strip
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Figure 2: An illustration of the hybrid prediction system. MPRAGE: Magnetization Prepared Rapid Gradient Echo. MRI: Magnetic Resonance Imaging. ReLU:
Rectified Linear Unit. Batch Norm: Batch Normalization.
algorithm, which is based on U-Net architecture [15] trained on
skull-stripping datasets [16], reduces the processing size of vol-
umes, thereby increasing computational speed during the train-
ing. After the skull-strip, we have applied MRI scale standard-
ization [17] to mitigate the intensity differences between the
MRI sequences.
The neural network architectures require the inputs to be
scaled in a consistent way for a stable and faster convergence.
Therefore, we normalize the images, scalar volumetric features,
and demographic and clinical data into the range between 0 and
1. The scalar regional volume features are divided by each sub-
jects whole-brain volume size for normalization. The demo-
graphic and clinical data contains categorical values (e.g., gen-
der and ethnicity) that are converted into numeric data. The
range for the numeric demographic data is between 0 and 1 to
ensure numerical stability.
2.4. Model Configuration of the Neural Network
The deep learning algorithm is based on a supervised neural
network that has a hybrid architecture with two main compo-
nents: (i) a 3D Convolutional Neural Network (3D-CNN) that
learns the brain morphology and patterns, and (ii) integration of
scalar volumetric features and non-imaging data (demographic
and clinical information) at the fully connected layer.
2.4.1. Convolutional Neural Network
The 3D-CNN processes MRI scans models the patterns and
structures in brain volume. Earlier layers of the model capture
the low-level features of brain details, while higher-level layers
learn abstract features. The layout of the 3D-CNN architec-
ture is employed from [14] that is proposed for MRI analysis
for AD/CN classification. The architecture consists of three
batches of convolutional layers with kernels of 3 × 3 × 3 ele-
ments. Each batch contains two convolutional layers with 32,
32, 64, 64 and 128, 128 filters, respectively. The batches are
then followed by a batch normalization that mitigates the over-
fitting and improves the system generalization by normalizing
the output of the convolutional layer [18]. After batch normal-
ization, max-pooling layers with 23, 33, and 43 sizes are used
for feature reduction and spatial invariance. The architecture
uses ReLU (Rectified Linear Unit) activation that introduces
nonlinearity to the system [19]. The output of the deepest con-
volutional layer is flattened and fed to the fully connected layer.
The architecture parameters are listed in Table 2.
2.4.2. Integration of Scalar Volumetric Features and Non-
Imaging Demographic and Clinical Data with CNN
The clinical and demographic information presumably con-
tains additional information that would help the classification
decision. To incorporate the non-imaging data for assessment
of its impact, we have changed the standard CNN architecture.
The convolutional part of CNN is the feature extraction compo-
nent of the architecture; the fully connected layer part is the
classifier component. The output of the final pooling layer,
which holds the imaging features, is flattened and fed into the
fully connected layer. The flattened imaging features and non-
imaging features create a concatenated vector as an input to
the dense layer. The rest part of the architecture is the classi-
fier component of the hybrid system, trained with this vector to
form the final prediction model. The concatenated dense layer
is then followed by a dropout layer [20] in which the system
temporarily ignores randomly selected neurons during the train-
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ing to prevent the system from memorizing the training data
with the intent to decrease overfitting. The final layer is another
dense layer with a softmax activation function with two nodes
that provide probabilities for slowly deteriorating/stable class
and rapidly deteriorating class. The architecture parameters are
listed in Table 2.
2.5. Addressing Overfitting
The voxel-based CNNs are prone to over-fitting due to high-
dimensional data, large number of parameters, and relatively
small number of cases to optimally train the system [21, 14, 22].
To address the relatively low number of patients, we utilized
augmentation strategies. We flipped MRI volumes such that left
and right hemispheres are reversed [14] and randomly tilted at
less than 5◦. We have also employed the regularization tech-
niques of dropout [20] and weight decays [23] in order to in-
crease the generalization capacity of the model. The parameters
of dropout and weight decays are listed in able 3.
3. Experiments
3.1. Implementation Details
The dataset used in the study consists of 569 subjects with
MPRAGE (MRI) scans and corresponding clinical data (c.f.,
Section 2.1). We perform 5-fold cross-validation to reduce the
performance difference due to relatively small size datasets and
provide more robust generalization performance. At each fold,
60% of the dataset is used to train the model, 20% is used for
model validation, and 20% of the dataset is used to test the
model.
The training parameters are listed in Table 3. We train the
model using Adam optimizer [24], which provides faster con-
vergence due to the velocity and acceleration components. As a
training strategy, we monitor the model performance and use
two early stopping callbacks to stop the training before the
model begins to overfit [25]. We set a large epoch value (c.f.,
Table 3, max epoch 400) as an upper bound iteration. The num-
ber of training iteration is decided automatically based on the
model performance on the validation and training set. If the val-
idation loss has started to increase during the training process,
the system triggers the early stopping callback. If the valida-
tion loss continues to increase for another 20 iterations, then
the system stops the training. The continuous increase in vali-
dation loss is an indication of overfitting. The second callback
is monitoring the training accuracy. If the training accuracy
reaches the maximum value, the early stopping callback stops
the training due to an indication of no further improvement in
the model. The weights are randomly initialized from scratch.
The model is developed in Python (version 3.6.8) using
Tensorflow Keras API (version 2.1.6 − t f ) and trained on an
Nvidia Quadro GV100 system with 32GB graphics cards with
CUDA/CuDNN v9 dependencies for GPU acceleration.
3.2. Evaluation
We built 3 models: (i) an imaging model based on a 3D-
CNN that processes brain MRI, (ii) a hybrid model that com-
bines the 3D-CNN component with brain-volume scalar data
and demographic and clinical information, and (iii) a model
that processes brain-volume scalar data and demographic and
clinical information. We assess the models’ prediction perfor-
mance in terms of accurately classifying the cognitive decline
on a test dataset at each test fold and average the evaluation met-
ric scores across all the models. The performance metrics used
in the study are Sensitivity, Specificity, Accuracy, PPV, NPV,
and AUC. Table 4 lists the performance metrics.
3.2.1. Imaging module prediction performance
The correlation between the morphological changes in
the brain (e.g., parenchymal volume loss) and AD is
known [26][27]. Based on a prior study [28], (i) MCI sub-
jects have medium atrophy of hippocampus; (ii) the brain mor-
phology in non-converters is similar to brain morphology in
CN, and converters are more similar to AD, and (iii) convert-
ers have more severe deterioration of neuropathology than non-
converters. Due to the correlation between the pathological
changes in brain morphology and the AD stages, we first mea-
sured how much we could predict the pace of the cognitive de-
cline of patients by processing only the baseline MRI scans
through a 3D-CNN. The system achieved 0.67 AUC for pre-
dicting the cognitive-decline class by processing only baseline
MRI sequences. The Receiver Operator Characteristic (ROC)
curve for this experiment is shown in Figure 3.(a).
3.2.2. Hybrid model prediction performance
The hybrid model processes the MRI sequences, brain vol-
ume scalar data, and demographic information (age, gender,
years of education, ethnicity, and race). Table 4 lists the per-
formance scores obtained with the proposed system in terms of
mean and standard deviation across the cross-validated folds.
The system achieved an accuracy of 63.3%, with a PPV of
56.9%, sensitivity of 60.8%, specificity of 65.2%, and NPV of
69% at threshold 0.5. The average AUC is 0.67. Adding the
brain volume and demographic information as scalar values to
the system increased the system performance from 0.67 AUC
to 0.70 AUC as shown in Figure 3.(b).
3.2.3. Brain Volume Scalar Data and Non-Imaging Clinical
Data Prediction Performance
The voxel-based convolutional neural networks are prone to
over-fitting due to high dimensional data, large number of pa-
rameters, but relatively low number of subject to optimally train
the system [21, 14, 22]. Although we utilize several regulariza-
tion techniques, we still observed over-fitting due to the 3D-
CNN module of the hybrid system. In this experiment, we re-
move the 3D-CNN module of the hybrid model and run the
experiments only using brain−volume scalar data with non-
imaging clinical data. The system achieved 0.70 average AUC
for cognitive decline class prediction as shown in Figure 4.(a).
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Layer(Type) Input Size (output shape) # of Filters Level of Pooling # of Parameters
Input (MRI) 130 × 116 × 83 0
Conv3D 130 × 116 × 83 32 – 896
Conv3D 130 × 116 × 83 32 – 27680
Batch Norm 130 × 116 × 83 32 – 128
Max Pooling 3D 65 × 58 × 41 32 2 0
Conv3D 65 × 58 × 41 64 – 55360
Conv3D 65 × 58 × 41 64 – 110656
Batch Norm 65 × 58 × 41 64 – 256
Max Pooling 3D 21 × 19 × 13 64 3 0
Conv3D 21 × 19 × 13 128 – 221312
Conv3D 21 × 19 × 13 128 – 442496
Batch Norm 21 × 19 × 13 128 – 512
Max Pooling 3D 5 × 4 × 3 128 4 0
Flatten 7680 0 Input (Metadata)
Dense 512 3932672 12
Concatenate 524 0
Dropout
Dense 256 134400
Dropout
Dense (Out) 2 514
Table 2: The architecture parameters of the proposed model. Each row represents a layer, and the input of a particular layer is the output of the previous layer. There
are two input layers: (1) processing MRI sequences, (2) processing meta-data. The meta-data input layer is added to the architecture at the Dense layer through a
Concatenate function.
(a) (b)
Figure 3: The plots depict the system performance for predicting cognitive-decline class. (a) The predictive model processed only MRI sequences with 3D-CNN;
average AUC is 0.67. (b) The hybrid predictive model is based on MRI sequences with 3D-CNN, brain-volume scalar data and non-imaging clinical data; the
average AUC = 0.70.
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(a) (b)
Figure 4: (a) The predictive model processes only scalar data (brain-volume and non-imaging clinical data); average AUC is 0.70. (ROC: Receiver Operator
Characteristic) (AUC: Area Under the Curve). (b) An illustration of the hybrid prediction system. MPRAGE: Magnetization Prepared Rapid Gradient Echo. MRI:
Magnetic Resonance Imaging. ReLU: Rectified Linear Unit. Batch Norm: Batch Normalization.
Parameter Value
Processing dimension of each MRI volume 116 × 130 × 83 voxels
Optimizer Adam [24]
Learning Rate 0.00005
β1 0.9
β2 0.999
 10−8
Loss Function categorical cross-entropy
Batch Size 16
Drop-out keep rate 0.5
L2 Weight Regularizer [23] Kernel coefficient 0.5
L2 Weight Regularizer Bias coefficient 1
Early stopping max epoch 400
Early stopping patience epoch 20
Table 3: Implementation Details - Parameters
3.3. Integration of Components
The literature has several techniques to combine data from
different resources. We summarized these studies in Sec-
tion 3.4. We utilized CNN-based architecture as a classifier
and combined the imaging features with non-imaging data at
a dense layer in a straightforward way, as in [14][29]. Note
that imaging features or non-imaging features should not dom-
inate the training. To our knowledge, there is not any CNN-
based study that adjusts the effects of modules on the predic-
tion results. External weights can be used to adjust the contri-
bution of one module over the other modules. However, these
weights are additional hyper-parameters of the system and can
be decided on train/validation subsets. In order to observe how
different weights affect the final decision, we have conducted
an additional experiment. We have multiplied scalar input val-
ues (scalar brain volumes and demographic data) with external
weight (coefficient value) and kept the MRI imaging weights
the same. The external weight adjusts the contribution of the
nodes to the classifier decision. The coefficient set is 0.5, 1,
and 1.5. Figure 4.(b) shows the performance of the model with
different coefficient values.
3.4. Comparison with the Literature
AD-MCI-CN Classification. The correlation between the
morphological changes in the brain (e.g., parenchymal volume
loss) and AD has been known for years [26][27]. The literature
has several studies with quantitative analysis of brain MRI to
assess AD (e.g., classification of AD vs. CN) [30] [14]. These
studies measured the volumes, cortical thickness, or shape of
various structures such as the hippocampus [28] or the whole
brain [14] to assess the disease and the severity of the disease
as a percentage of volume. For example, in [14], a 3D-CNN-
based framework is proposed to learn the imaging characteris-
tics of AD and CN through convolutional layers. The model is
further modified to diagnose MCI, the prodromal stage of AD.
In our study, instead of anatomy-disease correlation, we focus
on anatomy-function correlation. A comprehensive review of
AD detection/classification can be found in [31].
MCI-to-AD Conversion. Many researchers have attempted
to predict the conversion of MCI to AD using the correla-
tion between the morphological changes in the brain and dis-
ease progression [28]. The volumetric analysis of the brain
(especially the hippocampus and entorhinal cortex) produces
satisfactory results in predicting conversion to AD [32] [33].
One of the most commonly employed classifiers is the Sup-
port Vector Machine (SVM) [8] [34]. Recent studies utilize
deep-learning-based approaches using neural network classi-
fiers [28][35]; they show that predicting progressive MCI or
detecting MCI patients who later progress to AD is still a goal
of ongoing research [4] [9].
Hybrid Models. The clinical and demographic information
contains additional data that contributes to the algorithm deci-
sion. To our knowledge, the algorithms that incorporate clin-
ical data into MRI data results are limited [36]. In [14], age
and gender information are concatenated with imaging fea-
tures in a 3D-CNN architecture through additional nodes at
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Metric th = 0.2 Metric th =0.3 Metric th = 0.4 Metric th = 0.5 Metric th = 0.6 Metric th = 0.7 Metric th = 0.8 Metric th = 0.9
0.630 ± 0.024 0.644 ± 0.026 0.646± 0.008 0.633 ± 0.024 0.630 ± 0.034 0.628 ± 0.047 0.595 ± 0.047 0.549 ± 0.052
0.619 ± 0.045 0.611 ± 0.046 0.597 ± 0.022 0.569 ± 0.026 0.560 ± 0.035 0.550 ± 0.042 0.520 ± 0.039 0.488 ± 0.036
0.380 ± 0.103 0.490 ± 0.069 0.551 ± 0.072 0.608 ± 0.077 0.657 ± 0.068 0.755 ± 0.072 0.820 ± 0.088 0.890 ± 0.065
0.818 ± 0.076 0.760 ± 0.071 0.717 ± 0.059 0.652 ± 0.053 0.609 ± 0.061 0.532 ± 0.073 0.425 ± 0.106 0.292 ± 0.095
0.638 ± 0.023 0.665 ± 0.019 0.681 ± 0.018 0.690 ± 0.032 0.703 ± 0.037 0.744 ± 0.060 0.766 ± 0.068 0.787 ± 0.099
Table 4: The hybrid model prediction performance. Training: 60%, Validation: 20%, Test: 20% of ADNI baseline set. (FN=False Negatives, FP=False Positives,
NPV=Negative Predictive Value, PPV=Positive Predictive Value, TN=True Negatives, TP=True)
the fully connected layer. In [28], a CNN was trained with
local patches extracted from the hippocampus and combined
with FreeSurfer brain data. The algorithm extracted imag-
ing features through a CNN architecture and processed imag-
ing features and FreeSurfer brain data using principal compo-
nent analysis following by the Lasso regression algorithm. The
processed features were provided as input to a NN algorithm
that combined these features. In [36], the authors proposed a
multi-modal fusion model to classify MCI and CN cases. The
study employed two Multi-Layer Perceptron (MLP) architec-
tures to train non-imaging data and 2D-CNN to train the imag-
ing data. The predictive model processed the test scores of
mini-mental state examinations, the Wechsler memory scale
for logical memory, and MRI sequences. The predictions from
each NN block were then combined using majority voting. An-
other interesting study that combined baseline MRI with base-
line cognitive test scores was proposed in [8]. The cognitive
scores used in the study were Rey’s Auditory Verbal Learning
Test, Alzheimer’s Disease Assessment Scale cognitive subtest,
MiniMental State Examination, Clinical Dementia Rating Sum
of Boxes, and Functional Activities Questionnaire. The MRI,
age, and cognitive measurements were integrated as input fea-
tures to a random forest classifier. Another hybrid method was
proposed in [37] that combined MRI and FDG-PET images at
multiple scales within a NN framework. Six independent deep
NNs processed different scales of image sequences. Another
NN fused the features extracted from these first 6 DNN. The
algorithm was proposed to classify AD and NC cases. One of
the most recent studies is [35] that combined MRI sequences,
demographic, neuropsychological, and APOe4 genetic data to
predict MCI patients who have a likelihood of developing AD
within 3 years. The study combined the imaging data with
non-imaging data at the fully connected layer of their proposed
deep-learning-based architecture. We list the recent studies that
combined different sources of information in Table 5. Several
other detailed comparison tables can be found in [31][35] and
in [8].
This study. Unlike prior studies, we investigate the feasibil-
ity of predicting the rate of cognitive decline in MCI patients
at the first visit by processing only the baseline MRI and rou-
tinely collected clinical data. The training data is separated
into two classes based on MMSE-rate values. We train our
model with slowly deteriorating/stable or rapidly deteriorating
classes formed based on MMSE-rate values. Therefore, we do
not predict patients that convert to AD. However, some MCI
cases deteriorated faster than the others. We investigate the pre-
diction performance of our multi-modality architecture to pre-
dict the rapidly deteriorating cases based on information avail-
able at only the baseline visit. The proposed hybrid architec-
ture jointly learns brain patterns and morphology from MRI se-
quences and additional information from the demographic data.
To our knowledge, this is the first research study that investi-
gates the feasibility of predicting the rate of cognitive decline
by processing routine data collected at the first visit.
We follow the same concatenation approach as in [14] which
is proposed for disease detection. Another similar study pro-
posed in [28] trained a convolutional neural network with local
patches extracted from the hippocampus and combined the ex-
tracted information with FreeSurfer brain data. Our results are
similar in that combining CNN features with scalar brain data
features obtained with FreeSurfer increases the prediction per-
formance. However, our study has differences, since our model
(i) does not predict the MCI-to-AD conversion probability but
instead predicts the rate of cognition deterioration in MCI pa-
tients by utilizing only the first-visit data; (ii) identifies patterns
within the whole brain MRI instead of only the hippocampus,
and (iii) uses limited FreeSurfer brain data (6 additional vol-
ume elements) compared with the brain data used in [28] (325
additional data).
Although, we roughly compare our study with MC-to-AD
conversion studies, note that there are differences on approach-
ing the problem. To our knowledge, this is the first study
that predicts slowly deteriorating/stable or rapidly deteriorating
classes by processing routinely collected baseline clinical and
demographic data (Baseline MRI, Baseline MMSE, Scalar Vol-
umetric data, Age, Gender, Education, Ethnicity, Race). The
training data is built based on MMSE-rate values. Therefore,
how our study approach predicting progressive MCI is different
than the previous studies. Also note that our method uses only
baseline data, not the data that is not routinely asking during
visits (e.g., APOe4 genetic data) or longitudinal data.
4. Conclusions and Discussion
In this study, we investigate whether a machine learning-
based system can predict cognitive decline in MCI patients at
the initial visit by processing routinely collected clinical data.
Unlike other studies that focus on predicting MCI-to-AD con-
version or AD/CN/MCI classification, we approach the prob-
lem as an early prediction of cognitive decline rate in MCI pa-
tients. The ability to identify an individuals cognitive decline
rate potentially helps the clinician to develop early preventive
treatment strategies.
We observed the performances of 3 models for the predic-
tion of cognitive-decline class. Our results confirm that there
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Study Method Data Source Brain Region Objective Performance
This Study 3D-CNN Baseline MRI + Whole Brain Predicting AUC: 0.70
Multi-modal Baseline MMSE + Fast Decliners Acc: 63.3%
Demographic data + Sens:60.8%
Baseline Scalar Volume Spec:65.2%
Lee et al. [4] Recurrent NN Baseline MRI + Regional MCI-to-AD AUC: 0.86
Multi-modal Demographic data + Hippocampus Conversion Acc: 81%
Long. CSF biomarkers + Sens:84%
Long. Cognitive performance + Spec:80%
Lin et al. [28] 2.5D CNN Baseline MRI + Regional MCI-to-AD AUC: 0.86
Multi-modal 325 Free Surfer feature Hippocampus Conversion Acc: 79.9%
PCA + Lasso + NN Sens:84.0%
Spec:74.8%
Lu et al. [37] Multi-modal MRI + FDG-PET Whole Brain Stable MCI vs Acc: 82.9%
Multi-scale NN Long. time-points Progressive MCI Sens:79.7%
Spec:83.8%
Esmaeilzadeh et al. [14] Multi-modal MRI + Whole Brain AD-NC-MCI Acc: 94.1%
Age + Gender Classification Sens:94%
Sens:91%
Moradi et al. [8] Random Forest Baseline MRI + Age Whole Brain MCI-to-AD AUC: 0.9
Multi-modal Baseline Cognitive measurements + Conversion Acc: 82%
(RAVLT + ADAS-cog) Sens: 87%
(MMSE + CRD-SB + FAQ) Spec:74%
Spasov et al. [35] 3D-CNN MRI + Whole Brain MCI-to-AD AUC: 0.925
Multi-modal Demographic data + Conversion Acc: 86%
neuropsychological data + Sens: 87.5%
APOe4 genetic data Spec:85%
Table 5: ML: Machine Learning, 2D: 2-Dimension, 3D: 3 Dimension, NN: Neural Network, CNN: Convolutional Neural Network, R-CNN: Recurrent Convolutional
Neural Network, Acc: Accuracy, Sens: Sensitivity, Spec: Specificity, AUC: Area Under Curve. CSF: Cerebrospinal fluid, Long: Longitudinal, RAVLT: Rey’s
Auditory Verbal Learning Test, ADAS-cog: Alzheimer’s Disease Assessment Scale cognitive subtest, MMSE: MiniMental State Examination, CDR-SB: Clinical
Dementia Rating Sum of Boxes, FAQ: Functional Activities Questionnaire.
is a correlation between the cognitive decline and the clinical
data obtained at the first visit. The imaging model achieved
0.67 AUC. By adding brain volume and demographic informa-
tion as scalar values to the system, the performance increased
to 0.70 AUC. Processing brain volumes (from FreeSurfer brain
data) and demographic information as scalar values provide
similar results as the hybrid module performance. Even though
patient’s cognitive condition is mostly decided based on non-
imaging clinical data (e.g., MMSE score, patient age) at the
clinical visit, and MRI scans are generally collected to exclude
other brain pathology, our results show that the structural MRI
provides useful information related to the patient‘s cognitive
condition and may further contribute to the clinical evaluation
and follow-up of patients with MCI. We have conducted exper-
iments on Alzheimers Disease Neuroimaging Initiative (ADNI)
dataset (c.f., Section 2.1) due to the availability of longitudinal
MMSE scores and baseline clinical data. To our knowledge,
there is not any available dataset that has a rich source of infor-
mation regarding the Alzheimers Disease and its progression.
However, the system needs to be further investigated and vali-
dated on an independent dataset.
Our system performance is lower compared to the published
studies that investigate MCI-to-AD conversion or AD/CN clas-
sification by modeling disease progression by processing lon-
gitudinal data obtained at several visits or by processing ad-
ditional data that is not routinely obtained during visits (e.g.,
APOe4 genetic data). Note that predicting cognitive decline is
more challenging than AD/CN classification due to the subtle
nature of pathological changes [28]. Moreover, our system pro-
cessed only data that is routinely collected at the first visit, and
thus makes predictions based on much less information com-
pared to studies that incorporate follow-up data through time-
sequence analysis.
The clinical and demographic information contains addi-
tional data that contributes to the algorithm decision. In this
study, we utilized CNN-based architecture as a classifier and
combined the imaging features with non-imaging data at a
dense layer in a straightforward way. To our knowledge, there
is not any comprehensive study that investigates the best merg-
ing methods of different sources of information in CNN-based
architecture, and it is an open research area.
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